Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

122 results about "Meticillin" patented technology

Methicillin, also known as meticillin, is a narrow-spectrum β-lactam antibiotic of the penicillin class. Meticillin was discovered in 1960.

Antibacterial peptide with broad-spectrum antibacterial effect, antibacterial product and application

The invention belongs to the field of antibacterial peptides, and particularly relates to an antibacterial peptide with a broad-spectrum antibacterial effect, an antibacterial product and application. The antibacterial peptide is named as CAMP1111NC, and is obtained by performing N-terminal acetyl end capping and C-terminal amino end capping on polypeptide shown in SEQ ID NO: 1. The antibacterial peptide has remarkable antibacterial activity on a staphylococcus aureus standard strain ATCC12600, pseudomonas aeruginosa PAO1, klebsiella pneumoniae, an acinetobacter baumannii standard strain ATCC19606, methicillin-resistant staphylococcus aureus ATCC33591, methicillin-resistant and gentamicin-resistant staphylococcus aureus ATCC33592 and acinetobacter baumannii bio-53272 resistant to various antibiotics, and the antibacterial peptide can be used for preparing the antibacterial peptide. The limitation of the traditional antibacterial peptide is effectively overcome.
Owner:OCEAN UNIV OF CHINA

Membrane vesicle preparation for eliminating intracellular staphylococcus aureus infection as well as preparation method and application of membrane vesicle preparation

The invention provides a membrane vesicle preparation for removing intracellular staphylococcus aureus infection and application of the membrane vesicle preparation, membrane vesicles of a staphylococcus aureus low-toxicity strain RN4220 are separated and purified, vancomycin is loaded by adopting an ultrasonic method, and the removal preparation is prepared, so that efficient delivery of vancomycin into macrophages is realized; the methicillin-resistant staphylococcus aureus in the macrophages can be effectively removed. By adopting the preparation provided by the invention, vancomycin can be effectively loaded into staphylococcus aureus membrane vesicles, the number of methicillin-resistant staphylococcus aureus infection in mouse peritoneal macrophages is remarkably reduced, and the preparation has relatively good biocompatibility and safety.
Owner:ARMY MEDICAL UNIV

Novel antibacterial peptide GG25 and application thereof

The invention is applicable to the technical field of polypeptides, and provides a novel antibacterial peptide GG25 and application thereof, and the amino acid sequence of the antibacterial peptide GG25 is as shown in SEQ ID No.1. The molecular weight of the novel antibacterial peptide GG25 is 2890.52 Da, and the novel antibacterial peptide GG25 has antibacterial activity on escherichia coli, klebsiella pneumoniae, pseudomonas aeruginosa, enterococcus faecalis, salmonella typhimurium, methicillin-resistant staphylococcus aureus, staphylococcus aureus, staphylococcus epidermidis, listeria monocytogenes and bacillus subtilis; the hemolytic activity is low, the cytotoxicity is small, and the escherichia coli and methicillin-resistant staphylococcus aureus are not easily induced to generate drug resistance; in addition, the gelatin chitosan food coating containing GG25 also has a good beef preservation effect, and can be applied to the fields of food, animal husbandry, medicine and the like.
Owner:JILIN UNIVERSITY

Application of nanoparticles capable of forming spine array structure in preparation of medicine for repairing skin wound and pharmaceutical composition

The invention belongs to the field of nano-drugs, and particularly relates to application of nano-particles capable of forming a spine array structure in preparation of a drug for repairing skin wounds and a pharmaceutical composition, and the nano-particles are composed of a gold core and nano-hierochloe odorata distributed on the surface of the gold core, the nanoparticles can form a spine array structure on the surface of a skin wound for repairing the skin wound. The nanoparticles prepared by the invention can be uniformly and stably dispersed in ethanol, can be directly and simply sprayed by a sprinkling can, can be prepared into gel which can be used for a rat skin wound infected methicillin-resistant staphylococcus aureus model, and has a good antibacterial effect; the compound is superior to vancomycin which is a high-grade antibiotic aiming at methicillin-resistant staphylococcus aureus clinically at present. Meanwhile, wound healing and collagen deposition can be promoted, and inflammatory response caused by wound infection is slowed down.
Owner:WUHAN UNIV OF TECH

Preparation and biological activity application of single-layer Mo4VC4 nanosheet

The invention discloses an application of an Mxene-Mo4VC4 new member nano platform with light-enhanced peroxidase activity in treatment of methicillin-resistant staphylococcus aureus infection so as to promote healing of infected wounds, and belongs to the field of two-dimensional nano material catalyst antibacterial research. The single-layer Mo4VC4 nanosheet is synthesized on the basis of Mo4AlVC4-MXene through a hydrofluoric acid etching method. The Mo4VC4 nanosheet shows activity similar to peroxidase, and can locally catalyze low-concentration hydrogen peroxide and generate hydroxyl radicals toxic to bacteria, so that methicillin-resistant staphylococcus aureus is effectively killed, and a biological membrane is removed. In addition, high photo-thermal conversion efficiency and photo-thermal stability are shown under irradiation of near-infrared light with low concentration (50 mu g / mL). The similar peroxidase activity is obviously amplified by the temperature rise caused by the photothermal effect of the Mo4VC4 nanosheet. And finally, rapidly eliminating methicillin-resistant staphylococcus aureus in deep infection and accelerating abscess regression by adopting a satisfactory photo-thermal amplification peroxidase strategy.
Owner:WENZHOU MEDICAL UNIV

Antibacterial peptide with broad-spectrum antibacterial effect, antibacterial product and application

The invention belongs to the field of antibacterial peptides, and particularly relates to an antibacterial peptide with a broad-spectrum antibacterial effect, an antibacterial product and application. The antibacterial peptide is named as CAMP502NC, and is obtained through N-terminal acetyl end capping and C-terminal amino end capping of polypeptide shown in SEQ ID NO: 1. The antibacterial peptide has remarkable antibacterial activity on a staphylococcus aureus standard strain ATCC12600, pseudomonas aeruginosa PAO1, klebsiella pneumoniae, an acinetobacter baumannii standard strain ATCC19606, methicillin-resistant staphylococcus aureus ATCC33591, methicillin-resistant and gentamicin-resistant staphylococcus aureus ATCC33592 and acinetobacter baumannii bio-53272 resistant to various antibiotics, and the antibacterial peptide can be used for preparing the antibacterial peptide. The limitation of the traditional antibacterial peptide is effectively overcome.
Owner:OCEAN UNIV OF CHINA

Glucoside hydrolase with anti-biofilm activity and application thereof

The invention discloses glucoside hydrolase with anti-biofilm activity and application of the glucoside hydrolase. Experiments prove that the PgaBAb1 protein and the PgaBKp protein have remarkable anti-staphylococcus epidermidis biofilm activity and can destroy a mature staphylococcus epidermidis biofilm and inhibit formation of the staphylococcus epidermidis biofilm, that is, the PgaBAb1 protein and the PgaBKp protein are glucoside hydrolase with anti-biofilm activity; meanwhile, the sensitivity of the staphylococcus epidermidis to methicillin can be improved; the amino acid sequences of the PgaBAb1 protein and the PgaBKp protein are respectively as shown in SEQ ID NO: 5 and SEQ ID NO: 6. Therefore, both the PgaBAb1 protein and the PgaBKp protein can be used as active ingredients of drugs to treat diseases caused by infection of bacteria generating biological membranes and / or drug-resistant bacteria. The method has an important application value.
Owner:MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI

Application of fludarabine in treatment of methicillin-resistant staphylococcus aureus infection

The invention discloses application of fludarabine in treatment of methicillin-resistant staphylococcus aureus infection, and in an MRSA infected mouse model, it is verified that fludarabine can improve the survival rate of MRSA infected mice, reduce the MRSA bacterial count of lungs, livers, spleens and kidneys and relieve the injury degree of lungs, livers, spleens and kidneys caused by MRSA infection; pSMalpha3 is found to be an important virulence factor of MRSA, is closely related to high pathogenicity of MRSA, and can induce death of macrophages in a concentration-dependent manner, and fludarabine can significantly reduce cytotoxicity caused by PSMalpha3.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Low-voltage efficient sterilization electrode device based on local enhanced electric field treatment

The invention belongs to the technical field of biomedicine and nano material electronics, and particularly relates to a low-voltage efficient sterilization electrode device based on local enhanced electric field treatment. According to the electrode device, vertically-oriented nanoneedles serve as a core functional layer, a nanoneedle array is arranged on a conductive substrate, the intensity of an electric field in a pinpoint area is amplified by multiple times through the lightning rod effect induced by the tips of the nanoneedles so as to achieve irreversible electroporation of a low-potential induced pathogen membrane, the length of the nanoneedles is 5-100 micrometers, and the length of the nanoneedles is 5-100 micrometers. The curvature radius of the needle tip is lt; and the sterilization device can realize nearly complete sterilization on escherichia coli and methicillin-resistant staphylococcus aureus within 5 minutes. The invention further provides a nanometer microneedle sterilization patch based on the local enhanced electric field, a self-power-supply or external-source-power-supply energy supply mode is adopted, and rapid sterilization of a wound can be achieved without medicine adding.
Owner:SICHUAN UNIV

Lactobacillus plantarum capable of resisting various drug-resistant bacteria and application of lactobacillus plantarum

The invention discloses a lactobacillus plantarum resistant to various drug-resistant bacteria and application thereof.A strain of lactobacillus plantarum 6-14 is separated from collected faeces of wild birds, and the lactobacillus plantarum 6-14 has an obvious inhibition effect on various drug-resistant bacteria and non-drug-resistant bacteria; comprising the steps of inhibiting methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus faecalis, penicillin-resistant streptococcus pneumoniae, staphylococcus aureus, escherichia coli, salmonella enteritidis and salmonella typhimurium, and a foundation is laid for developing a good antibacterial probiotic preparation.
Owner:NANJING AGRICULTURAL UNIVERSITY

Method for determining the methicillin resistance of staphylococcus aureus strains

The present invention relates to a method for determining the methicillin-resistance properties of a Staphylococcus aureus strain present in a biological sample, the method comprising the following steps: •a) incubating the biological sample containing the Staphylococcus aureus strain for at least 15 minutes in the presence of an antibiotic from the class of beta-lactams selected from the following group: cefoxitin and 6-APA (6-aminopenicillanic acid); •b) isolating the bacteria present in the biological sample; •c) lysing the bacteria and hydrolysing the bacterial proteins in order to obtain a mixture of peptides; and •d) analysing this mixture of peptides by targeted mass spectrometry, the detection of at least one peptide originating from the protein PBP2a (SEQ ID NO. 1) or PBP2c (SEQ ID NO. 2) during this analysis step being indicative of the methicillin resistance of the Staphylococcus aureus strain present in the biological sample.
Owner:UNIV CLAUDE BERNARD LYON 1 +1

Application of shikimic acid as in-vivo synergist of vancomycin for treating methicillin-resistant staphylococcus aureus infectious endocarditis

The invention belongs to the technical field of disease treatment, and discloses application of shikimic acid as an in-vivo synergist of vancomycin for treating methicillin-resistant staphylococcus aureus infectious endocarditis. The shikimic acid and vancomycin are accidentally found to have no combined synergistic effect in vitro, but the shikimic acid and vancomycin can obviously reduce the bacterium loading amount in neoplasm in vivo, and the generation of inflammatory exudate (neoplasm) on heart valves of rats is obviously reduced; the shikimic acid is used as an in-vivo synergist of vancomycin for treating methicillin-resistant staphylococcus aureus infectious endocarditis, so that the antibacterial activity of vancomycin is improved, the treatment effect is improved, the dosage of vancomycin required by treatment is reduced, and the toxic and side effects of vancomycin are reduced. The research result can provide new theoretical basis and practical guidance for clinical treatment of MRSA infectious endocarditis, and has important scientific significance and application value.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

A 1,3,4-thiadiazole peptide deformylase enzyme inhibitor and preparation and application thereof

ActiveCN117886808BAcyl groupThiadiazoles
This invention relates to a 1,3,4-thiadiazole peptide deformylase inhibitor and its preparation and application. The structural formula is shown in formula (1): wherein, R 1 It is n-butyl or cyclopentylmethyl; R 2 The compounds are hydrogen-containing, straight-chain alkanes, cyclic alkanes, aromatic rings, substituted biphenyls, or heterocyclic rings. The 1,3,4-thiadiazole peptide deformylase inhibitors provided by this invention can effectively inhibit bacterial protein synthesis, thereby achieving sterilization. These compounds exhibit excellent inhibitory activity against Gram-positive drug-resistant bacteria, especially the clinically challenging methicillin-resistant Staphylococcus aureus (MRSA). In particular, some preferred compounds show inhibitory activity 4-8 times that of the control standards vancomycin and linezolid. The 1,3,4-thiadiazole peptide deformylase inhibitors provided by this invention also exhibit inhibitory activity against Gram-negative drug-resistant bacteria, especially against drug-resistant Acinetobacter baumannii, known as "superbugs," with an inhibitory activity reaching 0.5 μg / mL, far superior to vancomycin and linezolid.
Owner:SHANGHAI UNIV

Serine protease as well as preparation method and application thereof

The invention relates to the technical field of biological enzymes, and discloses serine protease as well as a preparation method and application thereof. Wherein the amino acid sequence of the serine protease is as shown in SEQ ID NO. 1 or SEQ ID NO. 2. The serine protease provided by the invention has stable activity at different temperatures, can better maintain the activity and efficacy in practical application, and can still effectively inhibit the formation of a biological membrane or remove a mature biological membrane under the condition of variable temperatures. Experimental results show that the serine protease can obviously inhibit the formation of the methicillin-resistant staphylococcus aureus biological membrane and remove the methicillin-resistant staphylococcus aureus biological membrane; no antibacterial activity is found, so that pathogenic bacteria are not easy to generate drug resistance; meanwhile, toxicity is avoided, and the germination rate and bud length of alfalfa seeds are not affected. Therefore, the serine protease is safe and reliable in application in the food industry, and has great advantages in food application.
Owner:SHENZHEN UNIV

Dihydropyrazole derivatives, preparation method thereof and application of dihydropyrazole derivatives in preparation of antibacterial drugs

The invention relates to the technical field of chemical synthesis, in particular to a dihydropyrazole derivative, a preparation method thereof and application of the dihydropyrazole derivative in preparation of antibacterial drugs. The dihydropyrazole derivative is prepared from corresponding raw materials through aldol condensation, Michael addition and acylation reaction, the reaction conditions are mild, the steps are simple, and the raw materials are low in cost and easy to obtain. The compound has excellent activity of resisting staphylococcus aureus, methicillin-resistant staphylococcus aureus, ampicillin-resistant staphylococcus aureus, pseudomonas aeruginosa and bacillus subtilis. The invention is of great significance to development and research of new antibacterial drugs.
Owner:SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES

Application of golden larch bark acetic acid in preparation of MRSA biological membrane and bacterium-retaining inhibitor

The invention relates to application of golden larch bark acetic acid in preparation of methicillin-resistant staphylococcus aureus (MRSA) biological membrane and bacterium holding inhibitor. A biological membrane formation inhibition experiment shows that the pseudolaric acid can remarkably inhibit formation of an MRSA biological membrane, a fluorescent quantitative PCR experiment shows that the pseudolaric acid remarkably reduces transcription of related genes of the MRSA biological membrane, and a persistent bacterium killing experiment shows that the pseudolaric acid enhances the killing capability of gentamicin on MRSA persistent bacteria. Lung epithelial cell adhesion tests find that the golden larch bark acetic acid significantly reduces the adhesion effect of the MRSA strain on epithelial cells. A test for constructing an MRSA infected greater wax moth model shows that the golden larch bark acetic acid has a system protection effect on the MRSA infected greater wax moth model.
Owner:JILIN TEACHERS INST OF ENG & TECH

Strain XY-144 as well as fermentation supernatant and application thereof

The invention relates to the technical field of microorganisms, and discloses a strain XY-144 as well as fermentation supernate and application thereof. Wherein the Latin classification name of the strain XY-144 is Fangia hongkongensis, the preservation unit is China General Microbiological Culture Collection Center, the preservation address is No.3, No.1 Yard, Beichen West Road, Chaoyang District, Beijing, the preservation number is CGMCC No: 31090, and the preservation date is June 26, 2024. Fermentation supernate prepared from the strain XY-144 can obviously inhibit formation of a methicillin-resistant staphylococcus aureus biological membrane and remove the methicillin-resistant staphylococcus aureus biological membrane, the thermal stability of the fermentation supernate is good, and antibacterial activity and toxicity are not found. Therefore, the strain XY-144 and its fermentation supernatant are safe and reliable in application in food industry, and have great advantages in food application.
Owner:SHENZHEN UNIV

Application of leonurine in preparation of antibacterial product

PendingCN121129824AOrganic active ingredientsCosmetic preparationsBiotechnologyMethicillin resistance
The invention relates to the field of modern pharmacy of traditional Chinese medicines, and discloses application of leonurine in preparation of antibacterial products. According to the invention, the in-vitro antibacterial activity of leonurine is detected by an agar dilution method and a broth trace dilution method. The result shows that the leonurine can inhibit the proliferation of a staphylococcus aureus standard strain, and also has an inhibiting effect on most of methicillin-sensitive staphylococcus aureus, methicillin-resistant staphylococcus aureus and methicillin-resistant coagulase-negative staphylococcus which are obtained by clinical separation; meanwhile, the leonurine can inhibit proliferation of a malassezia standard strain and a clinical isolated strain, also has an inhibiting effect on most of ketoconazole drug-resistant candida and ketoconazole dose dependence-sensitive candida obtained through clinical isolation, and can be used for preparing antibacterial pharmaceutical compositions and skin care products.
Owner:AFFILIATED HUSN HOSPITAL OF FUDAN UNIV

Quorum-sensing inhibitors and / or postbiotic metabolites and related methods

Described herein is a synergistic combination comprising a quorum-sensing inhibitor and / or postbiotic metabolite and an antibiotic. Typically, the postbiotic metabolite comprises at least one peptide. Related compositions, uses, and methods are also described, including methods for resensitizing resistant bacteria to an antibiotic, and methods of treating antibiotic-resistant infections, such as methicillin-resistant Staphylococcus aureus (MRSA).
Owner:MICROSINTESIS INC

Application of cell division protein FtsZ targeted inhibitor A3 in preparation of drug-resistant bacterium resisting drugs

The invention provides application of a cell division protein FtsZ targeted inhibitor in preparation of drugs for resisting drug-resistant bacteria, and belongs to the technical field of drug research and development, the inhibitor provided by the invention is a compound A3, the name is (1-methyl-2-((Z)-(3-methylbenzo [d] thiazol-2 (3H)-subunit) methyl)-4-((E)-4-(4-methylpiperazine-1-yl) styryl) quinoline-1-iodide, and the compound A3 has a structural formula shown in the description. The molecular formula of the compound is C32H33IN4S. The compound A3 has a remarkable inhibition effect on various drug-resistant bacteria, particularly has a very strong inhibition effect on vancomycin-resistant enterococcus and methicillin-resistant staphylococcus aureus, and can be used for remarkably improving the sensitivity of methicillin to the methicillin-resistant staphylococcus aureus.
Owner:Guangzhou Cadre and Talent Health Management Center (Guangzhou Talent Training Institute, Guangzhou Eleventh People’s Hospital, Guangzhou Public Employee Mental Health Service Center)

Method for rapidly screening methicillin-resistant staphylococcus aureus in oral cavity of wild animal

The invention belongs to the technical field of biology, and particularly relates to a method for screening methicillin-resistant staphylococcus aureus of oral samples of wild animals. The methicillin-resistant staphylococcus aureus is selectively cultured by adopting a culture medium composition with specific composition, and molecular biological detection is combined, so that the methicillin-resistant staphylococcus aureus is screened from a wild macaque oral cavity sample for the first time. According to the screening method, the screening efficiency of the methicillin-resistant staphylococcus aureus is greatly improved, the methicillin-resistant staphylococcus aureus can be rapidly, accurately and efficiently screened and enriched from a large number of samples, and technical support is provided for experimental research related to the methicillin-resistant staphylococcus aureus.
Owner:ANHUI UNIV

Manganese-based layered hydroxide modified by gold nanoparticles and preparation method thereof

The invention discloses a manganese-based layered hydroxide modified by gold nanoparticles and a preparation method thereof, and relates to the technical field of drug synthesis, and the key points of the technical scheme are as follows: the layered morphology of Mn-LDH is observed on the manganese-based layered hydroxide in a transmission electron microscope, and spherical AuNPs dispersed on the surface and edge of a laminate have a uniform particle size and a uniform particle size. EDS energy spectrum analysis finds that gold, manganese, magnesium, aluminum and carbon elements exist, the hydrated particle size is 312 nm, and the dispersity is good. The material can initiate an excellent photo-thermal effect under the irradiation of 808nm near-infrared light to generate active oxygen and hydroxyl radicals to destroy bacterial cell walls and cell membranes, and the antibacterial effect can reach 99%. In addition, the material can stimulate a local active immune function, promote T cell infiltration and realize active immune sterilization. The nano material shows a remarkable anti-infection effect in an in-vitro antibacterial experiment and an in-vivo osteomyelitis animal model experiment, and a new insight is provided for treating osteomyelitis caused by methicillin-resistant staphylococcus aureus.
Owner:THE 958TH ARMY HOSPITAL OF THE CHINESE PEOPLES LIBERATION ARMY

Preparation of 2-sulfydryl-1, 3, 4-thiadiazole-gold nanocluster comparable with vancomycin and application of 2-sulfydryl-1, 3, 4-thiadiazole-gold nanocluster in infection

The invention discloses a preparation method of a 2-sulfydryl-1, 3, 4-thiadiazole-gold nanocluster comparable with vancomycin and an application of the 2-sulfydryl-1, 3, 4-thiadiazole-gold nanocluster in infection, and the 2-sulfydryl-1, 3, 4-thiadiazole-gold nanocluster is used for treating methicillin-resistant staphylococcus aureus. The result shows that the 2-sulfydryl-1, 3, 4-thiadiazole-gold nanocluster can be adsorbed on the surface of bacteria, down-regulate a Na < + > / H < + > transporter on a cell membrane, influence the potential of the cell membrane, reduce the activity of bacterial ATPase synthetase and the generation of ATP, and finally show the effect of killing the bacteria. The 2-sulfydryl-1, 3, 4-thiadiazole-gold nanocluster is good in antibacterial stability, low in cytotoxicity and good in blood compatibility, and in a rat wound infection model experiment, the gold nanocluster has a relatively remarkable curative effect of promoting wound healing, is mainly characterized by reduction of local inflammation, increase of generation of blood vessels and collagenous fibers, down-regulation of inflammatory factors and the like, and can be used for preparing a drug for treating wound healing. And no obvious side effect is observed during the treatment period. The 2-sulfydryl-1, 3, 4-thiadiazole-gold nanocluster can be used as a material comparable to vancomycin and used for treating infection caused by methicillin-resistant staphylococcus aureus.
Owner:QUAN ZHOU SHI DI YI YI YUAN

Rationally designed lawsone derivatives as antimicrobials against multidrug-resistant Staphylococcus aureus

Naphthoquinone derivatives of Lawsone have been found to be effective against Staphylococcus aureus and methicillin resistant Staphylococcus aureus (MRSA). Such compounds generally contain a substituent group at the 3-position of a specific naphthoquinone compound, i.e. 2-hydroxy-1,4-naphthoquinone. One of these derivatives referred to as compound 6c in the series exhibits potent antimicrobial activity that is comparable to that of the two commercial antibiotics ofloxacin and ciprofloxacin against the two strains of methicillin sensitive Staphylococcus aureus (MSSA; ATCC 29213 and ATCC 6538). In the case of two strains of MRSA (ATCC BAA-44 and ATCC BAA-1717) that have developed drug resistance to both ofloxacin and ciprofloxacin, the antimicrobial activity of 6c can almost rival that of vancomycin and daptomycin. Furthermore, 6c is also effective against vancomycin-intermediate and daptomycin non-susceptible strain of MRSA (ATCC 700699). Besides the efficacy, 6c has a much improved drug resistance profile in comparison with the conventional antibiotics.
Owner:KENT STATE UNIV

Drug delivery systems for treatment of infections

Lipid-based drug delivery vehicles (including liposomal nanoparticles) are described which include antibiotic(s) for the treatment of infections, such as Methicillin-Resistant Staphylococcus (S.) aureus (MRSA) infections and Methicillin-Susceptible S. aureus (MSSA) infections. These drug delivery vehicles have high drug-loading, do not accumulate in the liver, and can optionally include one or more targeting ligands.
Owner:WAYNE STATE UNIV

Application of SX-682 in preparation of drugs for resisting staphylococcus aureus infection

The invention provides an application of SX-682 in preparation of a drug for resisting staphylococcus aureus infection, and the SX-682 has a CAS number of 1648843-04-2. According to the technical scheme, the novel medical application of the SX-682 is disclosed, and the SX-682 has better antibacterial activity on staphylococcus aureus and can inhibit formation of biofilms including methicillin-sensitive staphylococcus aureus (MSSA) and methicillin-resistant staphylococcus aureus (MRSA). The SX-682 has no significant toxicity to human cytotoxicity in the bacteriostatic concentration range, and provides key support for subsequent anti-infection application of the SX-682.
Owner:SHENZHEN NANSHAN DISTRICT PEOPLES HOSPITAL

Antibacterial peptide as well as composition and application thereof

The invention discloses an antibacterial peptide as well as a composition and application thereof, an amino acid sequence of the antibacterial peptide is shown as a formula I. The antibacterial peptide has a good antibacterial effect on methicillin staphylococcus aureus MRSA, methicillin-sensitive staphylococcus aureus MSSA and methicillin-resistant staphylococcus epidermidis MRSE, and the antibacterial peptide has a good antibacterial effect on methicillin-sensitive staphylococcus aureus MRSA, methicillin-sensitive staphylococcus aureus MSSA and methicillin-resistant staphylococcus epidermidis MRSE. The antibacterial peptide and the pharmaceutical composition prepared by adding auxiliary materials are expected to be widely applied to preparation of drugs for controlling or preventing microbial infection.
Owner:CHENGDU SINTANOVO BIOTECHNOLOGY CO LTD

Pharmaceutical composition and application thereof

The invention discloses a pharmaceutical composition and application thereof. The pharmaceutical composition contains the following components: homoplantaginin and amikacin which are stored independently or in a mixed manner of more than two of the homoplantaginin and the amikacin. According to the composition disclosed by the invention, homoplantaginin and amikacin are combined for use, and the homoplantaginin and amikacin play a synergistic effect, so that open wounds infected by methicillin-resistant staphylococcus (MRSA) can be effectively treated, and the effects of resisting inflammation, resisting oxidation and promoting healing are achieved.
Owner:THE SECOND XIANGYA HOSPITAL OF CENT SOUTH UNIV

Use of bacterial division protein ftsz inhibitor db1 in preparation of drug against drug-resistant bacteria

This invention discloses the application of the bacterial fission protein FtsZ inhibitor DB1 in the preparation of drugs against drug-resistant bacteria, belonging to the field of drug development technology. The inhibitor provided by this invention is compound DB1, named 3-(2,8-dibromo-10,11-dihydro-5H-dibenzo[b,f]azapheno-5-yl)-N,N-dimethylpropylamine hydrochloride, with the molecular formula C2. 19 H 24 Br2ClN2. This compound, DB1, exhibits significant inhibitory effects against various drug-resistant bacteria, particularly vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus (MRSA), and can significantly improve the susceptibility of methicillin to MRSA. The discovery of compound DB1 provides new ideas and technical support for the preparation of drugs against drug-resistant bacteria.
Owner:Guangzhou Cadre and Talent Health Management Center (Guangzhou Talent Training Institute, Guangzhou Eleventh People’s Hospital, Guangzhou Public Employee Mental Health Service Center)